Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Oxford BioMedica ( (GB:OXB) ) is now available.
Oxford Biomedica PLC announced that Dr. Heather Preston, a Non-Executive Director, purchased 11,389 ordinary shares of the company at £3.24 each on the London Stock Exchange. This transaction, compliant with EU Market Abuse Regulation, increases her total shareholding to 29,687 shares, representing 0.028% of the company. This purchase reflects confidence in the company’s strategic direction and may positively influence stakeholder perception.
The most recent analyst rating on (GB:OXB) stock is a Buy with a £740.00 price target. To see the full list of analyst forecasts on Oxford BioMedica stock, see the GB:OXB Stock Forecast page.
Spark’s Take on GB:OXB Stock
According to Spark, TipRanks’ AI Analyst, GB:OXB is a Neutral.
Oxford BioMedica’s overall score reflects strong revenue growth and positive corporate developments, offset by financial instability and mixed technical indicators. The company’s strategic initiatives and market momentum are promising, but profitability and cash flow concerns weigh heavily.
To see Spark’s full report on GB:OXB stock, click here.
More about Oxford BioMedica
OXB (LSE: OXB) is a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy. With 30 years of experience, the company is a pioneer in viral vectors, collaborating with leading pharmaceutical and biotechnology companies. OXB offers expertise in lentivirus, adeno-associated virus (AAV), adenovirus, and other viral vector types, providing services from early-stage development to commercialization. The company is headquartered in Oxford, UK, with facilities in the UK, France, and the US.
Average Trading Volume: 247,612
Technical Sentiment Signal: Sell
Current Market Cap: £342.2M
For an in-depth examination of OXB stock, go to TipRanks’ Overview page.